Skip to main content

Clinical Trials › NCT01892722

Active, Not RecruitingPhase 3

Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis

Sponsored by Novartis Pharmaceuticals

Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov
240
Target enrollment
8
U.S. states
Jul 2013
Start date
Feb 2030
Expected completion

Interventions / Treatments

Interferon beta-1aFingolimodPlacebo capsulePlacebo i.m. injection

Conditions studied

Multiple Sclerosis

Where this trial is running (10 sites)

California2 sites
Los Angeles · San Francisco
Florida2 sites
Miami · Tallahassee
Alabama1 site
Birmingham
Boston
Michigan1 site
Detroit
New Brunswick
Philadelphia
Utah1 site
Salt Lake City

MS centers in California

Compare treatment centers near a trial site by center type, providers and trials.

View California centers

More Phase 3 trials

Browse all Phase 3 MS trials
The app

Check out the MS Buddy app

Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.

Download on the App StoreGet it on Google Play